Literature DB >> 20712086

Medicare program; end-stage renal disease prospective payment system. Final rule.

.   

Abstract

This final rule implements a case-mix adjusted bundled prospective payment system (PPS) for Medicare outpatient end-stage renal disease (ESRD) dialysis facilities beginning January 1, 2011 (ESRD PPS), in compliance with the statutory requirement of the Medicare Improvements for Patients and Providers Act (MIPPA), enacted July 15, 2008. This ESRD PPS also replaces the current basic case-mix adjusted composite payment system and the methodologies for the reimbursement of separately billable outpatient ESRD services.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20712086

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  34 in total

1.  Survival with three-times weekly in-center nocturnal versus conventional hemodialysis.

Authors:  Eduardo Lacson; Jianglin Xu; Rita S Suri; Gihad Nesrallah; Robert Lindsay; Amit X Garg; Keith Lester; Norma Ofsthun; Michael Lazarus; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2012-02-23       Impact factor: 10.121

2.  Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose.

Authors:  Vimal K Derebail; Eduardo K Lacson; Abhijit V Kshirsagar; Nigel S Key; Susan L Hogan; Raymond M Hakim; Ann Mooney; Chinu M Jani; Curtis Johnson; Yichun Hu; Ronald J Falk; J Michael Lazarus
Journal:  J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 10.121

3.  Effect of Medicare dialysis payment reform on use of erythropoiesis stimulating agents.

Authors:  Shailender Swaminathan; Vincent Mor; Rajnish Mehrotra; Amal N Trivedi
Journal:  Health Serv Res       Date:  2014-10-30       Impact factor: 3.402

Review 4.  Considerations and challenges in defining optimal iron utilization in hemodialysis.

Authors:  David M Charytan; Amy Barton Pai; Christopher T Chan; Daniel W Coyne; Adriana M Hung; Csaba P Kovesdy; Steven Fishbane
Journal:  J Am Soc Nephrol       Date:  2014-12-26       Impact factor: 10.121

5.  Is It Too Much of a Good Thing? A New Era in Phosphate Binder Therapy in ESRD.

Authors:  Wajeh Y Qunibi
Journal:  J Am Soc Nephrol       Date:  2015-03-03       Impact factor: 10.121

6.  Health Policy for Dialysis Care in Canada and the United States.

Authors:  Marcello Tonelli; Raymond Vanholder; Jonathan Himmelfarb
Journal:  Clin J Am Soc Nephrol       Date:  2020-06-25       Impact factor: 8.237

7.  Home Dialysis in the Prospective Payment System Era.

Authors:  Eugene Lin; Xingxing S Cheng; Kuo-Kai Chin; Talhah Zubair; Glenn M Chertow; Eran Bendavid; Jayanta Bhattacharya
Journal:  J Am Soc Nephrol       Date:  2017-05-10       Impact factor: 10.121

8.  Facility Practice Variation to Help Understand the Effects of Public Policy: Insights from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Douglas S Fuller; Bruce M Robinson
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-10       Impact factor: 8.237

9.  Payment Reform and Health Disparities: Changes in Dialysis Modality under the New Medicare Dialysis Payment System.

Authors:  Marc Turenne; Regina Baker; Jeffrey Pearson; Chad Cogan; Purna Mukhopadhyay; Elizabeth Cope
Journal:  Health Serv Res       Date:  2017-05-30       Impact factor: 3.402

10.  Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients: Potential Impact of Changes in Intravenous Iron and Erythropoiesis-Stimulating Agent Dosing.

Authors:  Angelo Karaboyas; Jarcy Zee; Hal Morgenstern; Jacqueline G Nolen; Raymond Hakim; Kamyar Kalantar-Zadeh; Philip Zager; Ronald L Pisoni; Friedrich K Port; Bruce M Robinson
Journal:  Clin J Am Soc Nephrol       Date:  2015-08-18       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.